Moreover, as mentioned earlier, PD-L1 expression increased with TIL abundance in the EC ITME, indicating that PD-1 inhibitors can induce an effective anti-tumor immune response in EC with high PD-L1 expression (104–106). This evidence concerns the gene RPL17 and neoplasm.